Clinical trial · Interventional
A Comparative Study Between Laryngeal Mask Airway and Magensium Sulphate in Attenuating Systemic Stress Response During Emergence of Patients Undergoing Supratentorial Tumours.
NCT03406403CI-TRIAL-00033225completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate the efficacy of replacement of ETT with LMA and administration of Magnesium sulphate at the end of the surgery in attenuating systemic stress response during emergence of patients undergoing supratentorial tumours
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| LMA Versus Mgso4 in Attenuating Stress Response During Emergence of Supratentorial Tumours Patients | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Control group (closure of anesthetics) | Other | — | UNRESOLVED |
| Laryngeal mask airway | Device | — | UNRESOLVED |
| Magensium sulphate | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- Laryngeal mask airway group
- description
- 20 slips of papers will be taken and labeled as group L (LMA) These slips will be placed in an envelope and one slip will be raised for each patient.
- interventionNames
- Device: Laryngeal mask airway
- Drug: Magensium sulphate
- Other: Control group (closure of anesthetics)
- type
- ACTIVE_COMPARATOR
- label
- Magensium sulphate group
- description
- 20 slips of papers will be taken and labeled as group M (Mgso4) These slips will be placed in an envelope and one slip will be raised for each patient
- interventionNames
- Device: Laryngeal mask airway
- Drug: Magensium sulphate
- Other: Control group (closure of anesthetics)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: 1. ASA physical status I, II. 2. Ages between 18 and 60 years. 3. Body mass index (BMI) \< 30. 4. Elective surgery Exclusion Criteria: 1. Patients have cardiovascular, pulmonary, renal, hepatic and endocrine diseases. 2. Patients have any degree of disturbed conscious level. 3. Ages \<18 or \>60 years. 4. BMI \>30. 5. Patients have history of allergy to Magnesium sulphate. 6. Patients have uncontrolled hypertension during preoperative assessment. 7. Patients have risk of aspiration (eg. hiatus hernia) 8. Patients have difficult airway management during intubation with direct laryngoscope or time of intubation \>30 seconds. 9. Failed ventilation with LMA. 10. Emergency surgery.
References
Publications (0)
Data not yet available
No reference posted for this study.